Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer
暂无分享,去创建一个
Chen Sun | S. Srivastava | I. Sesterhenn | Yongmei Chen | G. Petrovics | D. Mcleod | A. Dobi | L. Ravindranath | Chen Sun | T. Sreenath | B. Furusato | J. Cullen | Jennifer Cullen | Yongmei Chen | Shiv Srivastava | Isabell A Sesterhenn | David G McLeod | Bungo Furusato | Gyorgy Petrovics | Ying Hu | Albert Dobi | Taduru Sreenath | Christopher Cook | Atekelt Y Tadase | Lakshmi Ravindranath | Rajesh L Thangapazham | Ahmed Mohamed | A. Mohamed | R. Thangapazham | Ying Hu | C. Cook | Atekelt Y. Tadase | Rajesh L. Thangapazham
[1] I. Kola,et al. Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. , 2004, Gene.
[2] Michael Ittmann,et al. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. , 2006, Cancer research.
[3] S. Srivastava,et al. Androgen receptor and prostate cancer , 2007, Prostate Cancer and Prostatic Diseases.
[4] Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival , 2008, Clinical Cancer Research.
[5] D. Turner,et al. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer , 2008, Expert review of anticancer therapy.
[6] R. Shah,et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. , 2007, Cancer research.
[7] Wei Zhang,et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients , 2004, Oncogene.
[8] R. Shah,et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.
[9] M. Rubin,et al. TMPRSS2-ETS fusion prostate cancer: biological and clinical implications , 2007, Journal of Clinical Pathology.
[10] Jianfeng Xu,et al. Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers , 2007, Genes, chromosomes & cancer.
[11] J. Brooks. Role of the TMPRSS2-ERG gene fusion in prostate cancer , 2008 .
[12] S. Leung,et al. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers , 2007, Journal of Clinical Pathology.
[13] R. Eeles,et al. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate , 2007, Oncogene.
[14] O. Kallioniemi. Functional genomics and transcriptomics of prostate cancer: promises and limitations , 2005, BJU international.
[15] Yao-Tseng Chen,et al. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues , 2007, Modern Pathology.
[16] J. Tchinda,et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.
[17] P. Nelson,et al. A causal role for ERG in neoplastic transformation of prostate epithelium , 2008, Proceedings of the National Academy of Sciences.
[18] R. Eeles,et al. Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. , 2008, The Journal of molecular diagnostics : JMD.
[19] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[20] J. Venables. Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[21] A. Seth,et al. ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.
[22] Stephen N. Jones,et al. An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis* , 2004, Journal of Biological Chemistry.
[23] Jianfeng Xu,et al. Inflammation in prostate carcinogenesis , 2007, Nature Reviews Cancer.
[24] S. Srivastava,et al. Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer , 2008, Modern Pathology.